The use of both datasets achieved a unified result; Kaplan-Meier survival analysis revealed that colon cancer patients with lower TNK2 expression had better prognoses than those with higher TNK2 expression (Figures 4A,B). The gene discussed is TNK2; the disease is colonic neoplasm.